Cardlytics Q3 revenue up 9% to $79M, net loss $(0.63)/share, adj. EBITDA turns positive $3.9M

Cardlytics, Inc.

2023-Q3 EPS reported -$0.95 revenue$220,037,000

Revenue $79.0M (+9% YoY); net loss $(24.0)M or $(0.63) per diluted share vs net income $6.3M in Q3 2022.
Adjusted EBITDA gain of $3.9M vs loss of $(12.7)M; non-GAAP net loss $0.3M ($0.01)/share.
Gross profit $35.8M (+38% YoY); billings $116.4M (+5% YoY).
MAUs 162.5M (+4% YoY); ARPU $0.49 vs $0.47.
Q4 2023 guidance: revenue $82-90M, adjusted EBITDA $4-8M.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Cardlytics, Inc. reported the third quarter ended September 30, 2023 results: revenue $79.0 million, net income $(24.0) million, or $(0.63) per diluted share, EPS $(0.63) per diluted share.

Period: the third quarter ended September 30, 2023
Revenue: $79.0 million
Net income: $(24.0) million, or $(0.63) per diluted share
EPS: $(0.63) per diluted share
Result: reported results

Exact text from the filing

EBITDA on an annual basis, while continuing to focus on profitability and improving our balance sheet and capital structure." Third Quarter 2023 Financial Results • Revenue was $79.0 million, an increase of 9% year-over-year, compared to $72.7 million in the third quarter of 2022. • Billings, a non-GAAP metric, was $116.4 million, an increase of 5% year-over-year,

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Cardlytics, Inc. filing history →

Source: SEC EDGAR

accession 0001666071-23-000147

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.